Anti-AP2 gamma/TFAP2C antibody [EPR20331]
- RabMAb
- Recombinant
- Advanced Validation
- What is this?
5
(1 Review)
|
(17 Publications)
Rabbit Recombinant Monoclonal AP2 gamma/TFAP2C antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra), IHC-P, mIHC and reacts with Human samples. Cited in 17 publications.
View Alternative Names
Transcription factor AP-2 gamma, AP2-gamma, Activating enhancer-binding protein 2 gamma, Transcription factor ERF-1, TFAP2C
- mIHC
Lab
Multiplex immunohistochemistry - Anti-AP2 gamma/TFAP2C antibody [EPR20331] (AB218107)
Panel A : anti-SIGLEC6 (green; Opal™520), anti-TFAP2C (magenta; Opal™690) and anti-PLVAP/PV-1 (gray; Opal™570) on human placenta. Panel B : anti-SIGLEC6 staining membrane of trophoblast in human placenta. Panel C : anti-TFAP2C staining nucleus of trophoblast in human placenta. Panel D : anti-PLVAP/PV-1 staining endothelium in human placenta. Nuclear DNA was labeled with DAPI (shown in blue). The section was incubated in three rounds of staining : in the order of ab317307, ab218107 and ab321889 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system. The immunostaining was performed on a Leica Biosystems BOND® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-AP2 gamma/TFAP2C antibody [EPR20331] (AB218107)
Immunohistochemical analysis of paraffin-embedded human breast cancer tissue labeling AP2 gamma/TFAP2C with ab218107 at 1/2000 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Nuclear staining on poorly differentiated human breast cancer is observed. The data is consistent with the literature (PMID : 18825690).
Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- mIHC
Lab
Multiplex immunohistochemistry - Anti-AP2 gamma/TFAP2C antibody [EPR20331] (AB218107)
Multiplex immunohistochemistry analysis of formalin/PFA-fixed paraffin-embedded human placenta tissue staining PAPP A2 with ab307087 at a 1/5000 dilution, ab218107 anti-TFAP2C used at 1/200 dilution and ab315802 anti-CD34 used at a 1/2000 dilution.
Panel A : anti-PAPP A2 (green; Opal™520), anti-TFAP2C (magenta; Opal™690) and anti-CD34 (gray; Opal™570) on human placenta.
Panel B : anti-PAPP A2 staining cytoplasm of trophoblast in human placenta.
Panel C : anti-TFAP2C staining nucleus of trophoblast in human placenta.
Panel D : anti-CD34 staining endothelium in human placenta.
Nuclear DNA was labeled with DAPI (shown in blue).
The section was incubated in three rounds of staining : in the order of ab307087, ab218107 and ab315802 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.
The immunostaining was performed on a Leica Biosystems BOND® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-AP2 gamma/TFAP2C antibody [EPR20331] (AB218107)
Immunofluorescent analysis of 4% paraformaldehyde-fixed 0.1% Triton X-100 permeabilized MCF7 (Human breast adenocarcinoma cell line) cells labeling AP2 gamma/TFAP2C with ab218107 at 1/500 dilution followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green).
Confocal image showing nuclear staining on MCF7 cell line.
The nuclear counterstain is DAPI (blue).
Tubulin is detected with ab195889 (Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594)) at 1/200 dilution (red).
Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) at 1/1000 dilution.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-AP2 gamma/TFAP2C antibody [EPR20331] (AB218107)
Immunohistochemical analysis of paraffin-embedded human breast cancer tissue labeling AP2 gamma/TFAP2C with ab218107 at 1/2000 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Almost all tumor cells show negative staining on moderately differentiated human breast cancer. The data is consistent with the literature (PMID : 18825690).
Counter stained with Hematoxylin.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-AP2 gamma/TFAP2C antibody [EPR20331] (AB218107)
Immunofluorescent analysis of 4% paraformaldehyde-fixed 0.1% Triton X-100 permeabilized SK-BR-3 (Human mammary gland adenocarcinoma cell line) cells labeling AP2 gamma/TFAP2C with ab218107 at 1/500 dilution followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green).
Confocal image showing nuclear staining on SK-BR-3 cell line.
The nuclear counterstain is DAPI (blue). Tubulin is detected with ab195889 (Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594)) at 1/200 dilution (red).
Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) at 1/1000 dilution.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-AP2 gamma/TFAP2C antibody [EPR20331] (AB218107)
Immunohistochemical analysis of paraffin-embedded human placenta tissue labeling AP2 gamma/TFAP2C with ab218107 at 1/2000 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Nuclear staining on human placenta is observed.
Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-AP2 gamma/TFAP2C antibody [EPR20331] (AB218107)
Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed SK-BR-3 (Human mammary gland adenocarcinoma cell line) cells labeling AP2 gamma/TFAP2Cwith ab218107 at 1/50 dilution (red) compared with a rabbit monoclonal IgG isotype control (ab172730; black) and an unlabeled control (cells without incubation with primary antibody and secondary antibody; blue). Goat anti rabbit IgG (Alexa Fluor® 488) at 1/2000 dilution was used as the secondary antibody.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-AP2 gamma/TFAP2C antibody [EPR20331] (AB218107)
Immunohistochemical analysis of paraffin-embedded human breast tissue labeling AP2 gamma/TFAP2C with ab218107 at 1/2000 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Nuclear staining on human normal breast is observed.
Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-AP2 gamma/TFAP2C antibody [EPR20331] (AB218107)
Immunohistochemical analysis of paraffin-embedded human seminoma tissue labeling AP2 gamma/TFAP2C with ab218107 at 1/2000 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Nucleus staining on human seminoma is observed.
Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IP
Supplier Data
Immunoprecipitation - Anti-AP2 gamma/TFAP2C antibody [EPR20331] (AB218107)
AP2 gamma/TFAP2C was immunoprecipitated from 0.35 mg of MCF7 (Human breast adenocarcinoma cell line) whole cell lysate with ab218107 at 1/30 dilution.
Western blot was performed from the immunoprecipitate using ab218107 at 1/1000 dilution.
VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.
Lane 1 : MCF7 whole cell lysate, 10 μg (Input).
Lane 2 : ab218107 IP in MCF7 whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab2018107 in MCF7 whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 10 seconds.
All lanes:
Immunoprecipitation - Anti-AP2 gamma/TFAP2C antibody [EPR20331] (ab218107)
Predicted band size: 49 kDa
Observed band size: 49 kDa
false
- WB
Supplier Data
Western blot - Anti-AP2 gamma/TFAP2C antibody [EPR20331] (AB218107)
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : Lane 1/2 : 30 seconds; Lane 3 : 10 seconds; Lane 4 : 3 minutes.
Lanes 1 - 2:
Western blot - Anti-AP2 gamma/TFAP2C antibody [EPR20331] (ab218107) at 1/1000 dilution
Lanes 3 - 4:
Western blot - Anti-AP2 gamma/TFAP2C antibody [EPR20331] (ab218107) at 1/2000 dilution
Lane 1:
SK-BR-3 (Human mammary gland adenocarcinoma cell line) whole cell lysate at 10 µg
Lane 2:
MDA-MB-435S (Human ductal carcinoma cell line) whole cell lysate at 10 µg
Lane 3:
MCF7 (Human breast adenocarcinoma cell line) whole cell lysate at 10 µg
Lane 4:
T-47D (Human ductal breast epithelial tumor cell line) whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 49 kDa
Observed band size: 49 kDa
false
Related conjugates and formulations (1)
-
Anti-AP2 gamma/TFAP2C antibody [EPR20331] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
AP2 gamma acts as a significant regulator of gene networks that control cell growth and differentiation. This protein contributes to transcriptional activation and repression often functioning within multiprotein complexes. It regulates the expression of genes involved in epithelial cell differentiation and morphogenesis. Importantly TFAP2C helps in the development of ectodermal tissues supporting cellular behaviors necessary for proper tissue formation.
Pathways
TFAP2C is involved in pathways that include developmental processes and differentiation. In particular it takes part in the Wnt signaling pathway influencing gene expression patterns that govern development. AP2 gamma interacts with proteins such as beta-catenin within the Wnt pathway modulating cell fate and proliferation. Another important pathway is the estrogen receptor signaling pathway where TFAP2C partners with proteins like ERα to regulate hormone-responsive genes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (17)
Recent publications for all applications. Explore the full list and refine your search
Genes & diseases 12:101565 PubMed40837414
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of clinical biochemistry and nutrition 77:1-9 PubMed40777819
2025
Applications
Unspecified application
Species
Unspecified reactive species
American journal of cancer research 15:894-928 PubMed40226463
2025
Applications
Unspecified application
Species
Unspecified reactive species
Biology direct 19:135 PubMed39716275
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular life sciences : CMLS 81:208 PubMed38710919
2024
Applications
Unspecified application
Species
Unspecified reactive species
Developmental cell 58:1477-1488.e5 PubMed37354899
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecular carcinogenesis 62:532-545 PubMed36752341
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell cycle (Georgetown, Tex.) 22:967-985 PubMed36710409
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell & bioscience 12:194 PubMed36457060
2022
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 8:eabo5668 PubMed35857527
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com